3rd Quarter - Report — VIAL HEALTH TECHNOLOGY, INC. for VIAL HEALTH TECHNOLOGY, INC. (2025)

Firm

VIAL HEALTH TECHNOLOGY, INC.

Client

VIAL HEALTH TECHNOLOGY, INC.

Income

—

Expenses

$280,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Regulatory and policy issues related to drug development and clinical trials

Lobbyist	Covered position, as disclosed
PAOLO MASTRANGELO	—

Contacted: Defense, Dept of (DOD); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; Vice President of the U.S.; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.